Surgery Partners, Inc.
SGRY
$17.07
$0.010.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.70M | -2.50M | -37.70M | -108.50M | -31.70M |
| Total Depreciation and Amortization | 39.50M | 40.30M | 36.30M | 33.90M | 50.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 85.20M | 60.20M | 64.30M | 217.50M | 74.90M |
| Change in Net Operating Assets | -18.40M | -16.70M | -56.90M | -31.50M | -28.20M |
| Cash from Operations | 83.60M | 81.30M | 6.00M | 111.40M | 65.20M |
| Capital Expenditure | -19.80M | -23.40M | -22.70M | -22.30M | -20.20M |
| Sale of Property, Plant, and Equipment | 0.00 | 38.10M | 4.80M | 1.10M | 0.00 |
| Cash Acquisitions | -4.60M | -4.00M | -44.00M | -87.60M | -26.60M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.80M | -8.60M | -14.50M | -2.90M | -2.80M |
| Cash from Investing | -46.20M | 2.10M | -76.40M | -111.70M | -49.60M |
| Total Debt Issued | 127.90M | 168.60M | 213.60M | 265.90M | 168.40M |
| Total Debt Repaid | -161.00M | -180.10M | -119.30M | -170.50M | -135.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -51.00M | -51.10M | -64.10M | -47.40M | -40.70M |
| Cash from Financing | -84.10M | -62.60M | 30.20M | 48.00M | -7.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.70M | 20.80M | -40.20M | 47.70M | 8.30M |